IGM Biosciences, Inc.
IGMSDelisted Aug 14, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496323
IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding IGM Biosciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 93 | 2 | 89 | −2 |
| Shares | 18.2M | 15.3K | 17.5M | −731.9K (−4.0%) |
| Value | $487.4M | $409.0K | $315.6M | −$171.4M (−35.2%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held IGM Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vident Investment Advisory, LLC | 48,946 | $882.0K | 0.03% |
| Ergoteles LLC | 38,500 | $694.0K | 0.02% |
| Simplex Trading, LLC | 28,642 | $516.0K | 0.02% |
| Jump Financial, LLC | 26,059 | $470.0K | 0.02% |
| Jane Street Group, LLC | 20,110 | $363.0K | 0.00% |
| Caxton Associates LP | 19,009 | $343.0K | 0.04% |
| New York Life Investment Management LLC | 17,446 | $315.0K | 0.00% |
| Bayesian Capital Management, LP | 16,900 | $305.0K | 0.06% |
| State Board of Administration of Florida Retirement System | 14,748 | $266.0K | 0.00% |
| Engineers Gate Manager LP | 11,531 | $208.0K | 0.01% |
| Alpha Paradigm Partners, LLC | 8,939 | $161.0K | 0.07% |
| Credit Suisse AG | 5,390 | $98.0K | 0.00% |
| MetLife Investment Management | 5,396 | $97.3K | 0.00% |
| STRS Ohio | 5,200 | $93.0K | 0.00% |
| Captrust Financial Advisors | 2,750 | $50.0K | 0.00% |
| Metropolitan Life Insurance Co | 626 | $11.3K | 0.00% |
| PFS Partners, LLC | 230 | $4.15K | 0.00% |
Sold out (19)
Institutions that held IGM Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Cormorant Asset Management, LP | 402,200 | $10.8M |
| EcoR1 Capital, LLC | 298,597 | $7.98M |
| Islet Management, LP | 131,700 | $3.52M |
| State of Wisconsin Investment Board | 43,800 | $1.17M |
| Squarepoint Ops LLC | 35,808 | $957.0K |
| Occudo Quantitative Strategies LP | 27,408 | $733.0K |
| HAP Trading, LLC | 22,814 | $610.0K |
| Susquehanna International Group, LLP | 18,578 | $497.0K |
| Two Sigma Investments, LP | 18,057 | $483.0K |
| Tudor Investment Corp Et Al | 14,639 | $391.0K |
| Schonfeld Strategic Advisors LLC | 11,500 | $308.0K |
| ExodusPoint Capital Management, LP | 10,728 | $287.0K |
| CSS LLC | 10,300 | $275.0K |
| Brookfield Asset Management Inc. | 7,500 | $200.0K |
| Parallax Volatility Advisers, L.P. | 1,962 | $53.0K |
| Ikarian Capital, LLC | 1,587 | $43.0K |
| Cutler Group LP | 700 | $18.0K |
| Quantbot Technologies LP | 460 | $12.0K |
| Advisor Group Holdings, Inc. | 200 | $5.00K |
Not filed for Q2 2022 yet (2)
Institutions that held IGM Biosciences, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| IndexIQ Advisors LLC | 13,971 | $373.0K |
| Amalgamated Financial Corp. | 1,335 | $36.0K |